nach oben

Erschienen in:

04.05.2021 | Original Research

Influence of Opioid Prescription Policy on Overdoses and Related Adverse Effects in a Primary Care Population

verfasst von: Valerie S. Harder, PhD, MHS, Timothy B. Plante, MD, MHS, Insu Koh, PhD, Ethan B. Rogers, BS, Susan E. Varni, PhD, Andrea C. Villanti, PhD, MPH, John R. Brooklyn, MD, Kathleen M. Fairfield, MD, MPH, DrPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

In response to the opioid epidemic, many states have enacted policies limiting opioid prescriptions. There is a paucity of evidence of the impact of opioid prescribing interventions in primary care populations, including whether unintended consequences arise from limiting the availability of prescribed opioids.

Objective

Our aim was to compare changes in opioid overdose and related adverse effects rate among primary care patients following the implementation of state-level prescribing policies.

Design

A cohort of primary care patients within an interrupted time series model.

Participants

Electronic medical record data for 62,776 adult (18+ years) primary care patients from a major medical center in Vermont from January 1, 2016, to June 30, 2018.

Interventions

State-level opioid prescription policy changes limiting dose and duration.

Main Measures

Changes in (1) opioid overdose rate and (2) opioid-related adverse effects rate per 100,000 person-months following the July 1, 2017, prescription policy change.

Key Results

Among primary care patients, there was no change in opioid overdose rate following implementation of the prescribing policy (incidence rate ratio; IRR: 0.64, 95% confidence interval; CI: 0.22–1.88). There was a 78% decrease in the opioid-related adverse effects rate following the prescribing policy (IRR: 0.22, 95%CI: 0.09–0.51). This association was moderated by opioid prescription history, with decreases observed among opioid-naïve patients (IRR: 0.18, 95%CI: 0.06–0.59) and among patients receiving chronic opioid prescriptions (IRR: 0.17, 95%CI: 0.03–0.99), but not among those with intermittent opioid prescriptions (IRR: 0.51, 95%CI: 0.09–2.82).

Conclusions

Limiting prescription opioids did not change the opioid overdose rate among primary care patients, but it reduced the rate of opioid-related adverse effects in the year following the state-level policy change, particularly among patients with chronic opioid prescription history and opioid-naïve patients. Limiting the quantity and duration of opioid prescriptions may have beneficial effects among primary care patients.

Nur mit Berechtigung zugänglich

Seth P, Rudd RA, Noonan RK, Haegerich TM. Quantifying the Epidemic of Prescription Opioid Overdose Deaths. Am J Public Health 2018;108(4):500-2. doi:https://doi.org/10.2105/AJPH.2017.304265CrossRefPubMedPubMedCentral

Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16(5):405-16. doi:https://doi.org/10.1037/a0013628CrossRefPubMedPubMedCentral

Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006;81(2):103-7. doi:https://doi.org/10.1016/j.drugalcdep.2005.05.009CrossRefPubMed

Institute of Medicine Committee on Advancing Pain Research Care and Education. The National Academies Collection: Reports funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011. Available from: https://www.nap.edu/catalog/13172/relieving-pain-in-america-a-blueprint-for-transforming-prevention-care.

Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006;21(6):607-12. doi:https://doi.org/10.1111/j.1525-1497.2006.00415.xCrossRefPubMedPubMedCentral

Tompkins DA, Hobelmann JG, Compton P. Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma. Drug Alcohol Depend 2017;173:11-21. doi:https://doi.org/10.1016/j.drugalcdep.2016.12.002CrossRef

Merboth MK, Barnason S. Managing pain: the fifth vital sign. Nursing Clinics of North America Journal 2000;35(2):375-83.

Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012. Am J Prev Med 2015;49(3):409-13. doi: https://doi.org/10.1016/j.amepre.2015.02.020CrossRefPubMedPubMedCentral

Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. Am J Public Health 2018;108(10):1394-400. doi:https://doi.org/10.2105/AJPH.2018.304590CrossRefPubMedPubMedCentral

10.

Vermont Department of Health. Rule Governing the Prescribing of Opioids for Pain. In: Vermont Department of Health. 2017. Available from: https://www.healthvermont.gov/sites/default/files/documents/pdf/REG_opioids-prescribing-for-pain.pdf.

11.

MacLean CD, Fujii M, Ahern TP, et al. Impact of Policy Interventions on Postoperative Opioid Prescribing. Pain Med 2019;20(6):1212-8. doi:https://doi.org/10.1093/pm/pny215CrossRefPubMed

12.

Dave CV, Patorno E, Franklin JM, et al. Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions. J Gen Intern Med 2019;34(11):2339-41. doi:https://doi.org/10.1007/s11606-019-05150-zCrossRefPubMedPubMedCentral

13.

Fujii MH, Malhotra AK, Jones E, Ahern TP, Fabricant LJ, Colovos C. Postoperative Opioid Prescription and Usage Patterns: Impact of Public Awareness and State Mandated-Prescription Policy Implementation. J Am Coll Surg 2019;229(4, Supplement 1):S109. doi: https://doi.org/10.1016/j.jamcollsurg.2019.08.245CrossRef

14.

Rubin R. Limits on Opioid Prescribing Leave Patients With Chronic Pain Vulnerable. JAMA. 2019;321(21):2059-62. doi:https://doi.org/10.1001/jama.2019.5188CrossRefPubMed

15.

O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016. Morb Mortal Wkly Rep 2017;66(43):1197-202. doi:https://doi.org/10.15585/mmwr.mm6643e1CrossRef

16.

Hooten WM, St Sauver JL, McGree ME, Jacobson DJ, Warner DO. Incidence and Risk Factors for Progression From Short-term to Episodic or Long-term Opioid Prescribing: A Population-Based Study. Mayo Clin Proc 2015;90(7):850-6. doi:https://doi.org/10.1016/j.mayocp.2015.04.012CrossRefPubMed

17.

Raebel MA, Newcomer SR, Reifler LM, et al. Chronic Use of Opioid Medications Before and After Bariatric Surgery. JAMA. 2013;310(13):1369-76. doi:https://doi.org/10.1001/jama.2013.278344CrossRefPubMed

18.

Epic Systems Corporation. EpicCare. Verona, WI 2020. Available from: https://www.epic.com/.

19.

Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18(12):1166-75. doi:https://doi.org/10.1002/pds.1833CrossRefPubMed

20.

Von Korff M, Saunders K, Ray GT, et al. Defacto long-term opioid therapy for non-cancer pain. Clin J Pain 2008;24(6):521.CrossRef

21.

Imam MZ, Kuo A, Ghassabian S, Smith MT. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology. 2018;131:238-55. doi:https://doi.org/10.1016/j.neuropharm.2017.12.032CrossRefPubMed

22.

Kiyatkin EA. Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology. 2019;151:219-26. doi:https://doi.org/10.1016/j.neuropharm.2019.02.008CrossRefPubMedPubMedCentral

23.

R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. Version 3.5.1 ed. Vienna, Austria 2014. Software. Available from: http://www.R-project.org.

24.

StataCorp. Stata Statistical Software. Release 15 ed. College Station, TX: StataCorp LP; 2017. Software.

25.

Lowenstein M, Hossain E, Yang W, et al. Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis. J Gen Intern Med 2020;35(3):662-71. doi:https://doi.org/10.1007/s11606-019-05302-1CrossRefPubMed

26.

Krebs EE. Evaluating Consequences of Opioid Prescribing Policies. J Gen Intern Med 2020:1-2. doi: https://doi.org/10.1007/s11606-019-05600-8

27.

Brooklyn J, Sigmon S. Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact. J Addict Med 2017;11(4):286-92. doi:https://doi.org/10.1097/adm.0000000000000310CrossRefPubMedPubMedCentral

28.

Vermont Department of Health. Opioid Use Disorder (OUD) Treatment Census and Waitlist as of November 2019. January 2020. Available from: https://www.healthvermont.gov/sites/default/files/documents/pdf/ADAP_OpioidUseDisorderTreatmentCensusandWaitList.pdf.

29.

O’Neill K. Evolution of an Epidemic: A Timeline of the Vermont Opioid Crisis. Saven Days VT. 2019. Available from: https://www.sevendaysvt.com/vermont/evolution-of-an-epidemic-a-timeline-of-the-vermont-opioid-crisis/Content?oid=25605835.

30.

Burke LG, Zhou X, Boyle KL, et al. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction. 2020;115(3):493-504. doi:https://doi.org/10.1111/add.14867CrossRefPubMed

31.

Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Intern Med 2016;176(9):1286-93. doi:https://doi.org/10.1001/jamainternmed.2016.3298CrossRefPubMedPubMedCentral

32.

Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790. doi:https://doi.org/10.1136/bmj.j5790CrossRefPubMedPubMedCentral

33.

Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624-45.CrossRef

34.

Steinberg J. Special Edition: The Opioid Epidemic. In: Primary Health Care Digest. Health Resources and Services Administration,. 2018. https://content.govdelivery.com/accounts/USHHSHRSA/bulletins/1e8d493.

35.

Harder VS, Varni SE, Murray KA, et al. Prescription Opioid Policies and Associations with Opioid Overdose and Related Adverse Effects. International Journal of Drug Policy. Under Revised Review 2021.

36.

Spooner L, Fernandes K, Martins D, et al. High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study. PLoS One 2016;11(12):e0167479. doi:https://doi.org/10.1371/journal.pone.0167479CrossRefPubMedPubMedCentral

37.

Lapham G, Boudreau DM, Johnson EA, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend 2020;207:107732. doi: https://doi.org/10.1016/j.drugalcdep.2019.107732CrossRefPubMed

Titel: Influence of Opioid Prescription Policy on Overdoses and Related Adverse Effects in a Primary Care Population
verfasst von: Valerie S. Harder, PhD, MHS
Timothy B. Plante, MD, MHS
Insu Koh, PhD
Ethan B. Rogers, BS
Susan E. Varni, PhD
Andrea C. Villanti, PhD, MPH
John R. Brooklyn, MD
Kathleen M. Fairfield, MD, MPH, DrPH
Publikationsdatum: 04.05.2021
Verlag: Springer International Publishing
Erschienen in: Journal of General Internal Medicine / Ausgabe 7/2021
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-021-06831-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Objective

Design

Participants

Interventions

Main Measures

Key Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2021

Impact of Inpatient Addiction Consultation on Hospital Readmission

CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial

Patient Experiences with Screening and Assistance for Social Isolation in Primary Care Settings

Development of the AL-O-A Score for Delirium Screening in Acute Internal Medicine: a Monocentric Prospective Study

Exercises in Clinical Reasoning: Digesting a Bloated Differential Diagnosis

Significance of Multiple Adverse Social Determinants of Health on the Diagnosis, Control, and Management of Diabetes